Assessing Human Genetic Variations in Glucose Transporter SLC2A10 and Their Role in Altering Structural and Functional Properties
Purpose: Demand is increasing for clinical genomic sequencing to provide diagnoses for patients presenting phenotypes indicative of genetic diseases, but for whom routine genetic testing failed to yield a diagnosis. DNA-based testing using high-throughput technologies often identifies variants with...
Main Authors: | Michael T. Zimmermann, Raul Urrutia, Margot A. Cousin, Gavin R. Oliver, Eric W. Klee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2018.00276/full |
Similar Items
-
Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics
by: Corinna Ernst, et al.
Published: (2018-03-01) -
The E273del variant of uncertain significance of the ornithine transcarbamylase gene - a case for reclassification
by: Nicole Ducich, et al.
Published: (2020-06-01) -
The VAAST Variant Prioritizer (VVP): ultrafast, easy to use whole genome variant prioritization tool
by: Steven Flygare, et al.
Published: (2018-02-01) -
Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain Significance
by: Steven Sorscher, et al.
Published: (2017-07-01) -
“The molecule’s the thing:” the promise of molecular modeling and dynamic simulations in aiding the prioritization and interpretation of genomic testing results [version 3; referees: 2 approved, 1 approved with reservations]
by: Gavin R. Oliver, et al.
Published: (2016-07-01)